US Patent 7935350 Ii-key/Her-2/neu hybrid cancer vaccine
Patent 7935350 was granted and assigned to Antigen Express on May, 2011 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 13, 2007
Date of Patent
May 3, 2011
Patent Application Number
12002083
Patent Inventor Names
Robert E. Humphreys
0
Minzhen Xu
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7935350 Ii-key/Her-2/neu hybrid cancer vaccine
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
